Skip to search formSkip to main contentSkip to account menu

10-methoxy-9-nitrocamptothecin

Known as: MONCPT cpd 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Camptothecin
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
P53 and p38 MAPK pathways are involved in MONCPT-induced cell cycle G2/M arrest in human non-small cell lung cancer A549
PurposeIn previous research, we found that 10-methoxy-9-nitrocamptothecin (MONCPT) possessed potent anti-tumor activity in A549… 
2009
2009
A Novel Camptothecin Derivative Incorporated in Nano-Carrier Induced Distinguished Improvement in Solubility, Stability and Anti-tumor Activity Both In Vitro and In Vivo
PurposeAn oil/water nanoemulsion was developed in the present study to enhance the solubility, stability and anti-tumor activity… 
2009
2009
MONCPT exerts anti-cancer activities via inducing G2/M arrest and apoptosis in human bladder cancer.
PURPOSE The potent anti-cancer capability of a novel CPT derivarate, 10-methoxy-9-nitrocamptothecin (MONCPT), has been… 
2006
2006
Potent antitumor activity of 10-methoxy-9-nitrocamptothecin
The present data showed that 10-methoxy-9-nitrocamptothecin (MONCPT), a family of camptothecin analogues, possessed high… 
2006
2006
Antiangiogenesis response of endothelial cells to the antitumour drug 10-methoxy-9-nitrocamptothecin.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)